Inventor · disambiguated record
Qingjie Liu
Also filed as: LIU QINGJIE
29 granted patents·10 pending applications·329 citations·filing 2001–2024
96Inventor score
Files withBRISTOL MYERS SQUIBB CO25BAYER PHARMACEUTICALS CORP8BAYER HEALTHCARE LLC1LEE WENDY1LIU CHUNJIAN1
Top patents by PatentIndex Score
39 records- 0196US10000480B2Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jun 19, 2018·20 cites·14 claims
- 0294US9688629B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jun 27, 2017·6 cites·21 claims
- 0394US8685969B2Carboline carboxamide compounds useful as kinase inhibitorsLIU CHUNJIAN·Filed 2011·Granted Apr 1, 2014·53 cites·15 claims
- 0494US8362065B2Carbazole carboxamide compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Granted Jan 29, 2013·32 cites·20 claims
- 0594US7838524B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerBAYER HEALTHCARE LLC·Filed 2005·Granted Nov 23, 2010·50 cites·37 claims
- 0693US8084620B2Carbazole carboxamide compounds useful as kinase inhibitorsLIU QINGJIE·Filed 2009·Granted Dec 27, 2011·60 cites·22 claims
- 0791US8207166B2Substituted pyrazolyl urea derivatives useful in the treatment of cancerLEE WENDY·Filed 2010·Granted Jun 26, 2012·24 cites·6 claims
- 0890US9815859B2Tricyclic sulfones as RORγ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 14, 2017·11 cites·15 claims
- 0987US2025243193A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1086US6660752B22,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 9, 2003·24 cites·30 claims
- 1185US9334290B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted May 10, 2016·5 cites·20 claims
- 1285US6900205B21,8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2002·Granted May 31, 2005·19 cites·36 claims
- 1384US2023192645A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1483US9920031B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 20, 2018·1 cites·14 claims
- 1583US8815840B2Carbazole and carboline kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted Aug 26, 2014·5 cites·6 claims
- 1680US9802915B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 31, 2017·1 cites·15 claims
- 1776US11623921B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 11, 2023·0 cites·7 claims
- 1876US7109196B21,8 Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 19, 2006·7 cites·20 claims
- 1976US2022356180A1Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2073US10604504B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 31, 2020·0 cites·14 claims
- 2172US6699860B2Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2001·Granted Mar 2, 2004·8 cites·20 claims
- 2272US2020165222A1Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 2369US10329274B2Indole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 25, 2019·0 cites·14 claims
- 2469US9714234B2Carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jul 25, 2017·1 cites·9 claims
- 2568US11053197B2Carbazole derivativesBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jul 6, 2021·0 cites·23 claims
- 2668US10676434B2Carbazole derivativesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 9, 2020·0 cites·8 claims
- 2767US10435415B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Oct 8, 2019·0 cites·11 claims
- 2867US2019382416A1Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Application pending·0 cites
- 2966US6919371B22,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2003·Granted Jul 19, 2005·2 cites·24 claims
- 3065US10106559B2Substituted tetrahydrocarbazole and carbazole carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Oct 23, 2018·0 cites·11 claims
- 3159US2006189609A11, 8-Naphthyridine derivatives and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2006·Application pending·0 cites
- 3257US2016194338A1Substituted tetrahydrocarbazole and carbazoles carboxamide compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3353US10266491B2Carbazole derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 23, 2019·0 cites·9 claims
- 3453US2005215594A12,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonistsBAYER PHARMACEUTICALS CORP·Filed 2005·Application pending·0 cites
- 3547US2023150979A1Amide-disubstituted pyridine or pyridazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3643US8207172B2Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disordersZHANG CHENGZHI·Filed 2005·Granted Jun 26, 2012·0 cites·13 claims
- 3743US2006094714A1Compounds and their use to treat diabetes and related disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Application pending·0 cites
- 3841US10934286B2Heterocyclic sulfones as ROR gamma modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 2, 2021·0 cites·20 claims
- 3935US10214537B2Bicyclic heteroaryl amine compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 26, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Qingjie Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →